Revista Espanola de Quimioterapia

Papers
(The median citation count of Revista Espanola de Quimioterapia is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Insights for COVID-19 in 202350
New variants of SARS-CoV-248
Pharmacological treatment of COVID-19: an opinion paper45
Temporary hospitals in times of the COVID pandemic. An example and a practical view36
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination36
Monkeypox in humans: a new outbreak30
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?28
Aspiration pneumonia23
COVID-19: Impact on prescribing and antimicrobial resistance20
Real-life use of remdesivir in hospitalized patients with COVID-1920
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting18
Dalbavancin15
Post-COVID syndrome: A reflection and opinion paper14
Recommendations on the use of azole antifungals in hematology-oncology patients12
Respiratory co-and superinfections in COVID-1911
High level of medication regimen complexity index correlate with worse quality of life in people living with HIV11
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain 10
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers10
Antiviral drugs against SARS-CoV-210
New definitions of susceptibility categories EUCAST 2019: clinic application10
Ceftazidime-avibactam10
Vaccine against COVID-199
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences9
The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-198
Cefiderocol8
Sexually transmitted infections in Spain: Current status8
Antimicrobial stewardship programs in emergency departments: how do we measure antimicrobial use? A systematic review8
Antimicrobial resistance and One Health8
Ceftolozane-tazobactam: When, how and why using it?8
Booster or additional vaccination doses in patients vaccinated against COVID-198
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies7
Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study7
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria7
Experience with the use of siltuximab in patients with SARS-CoV-2 infection7
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker7
Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections7
Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study7
Latent tuberculosis infection: approach and therapeutic schemes6
Emergency detection of HIV infection in patients consulting for conditions potentially related to occult infection: Initial results of the “Urgències VIHgila” program6
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection6
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-neg6
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience6
Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital6
Recommendations for antibiotic selection for severe nosocomial infections6
Oral antibiotic treatment of exacerbation of COPD. Beyond COVID-196
Impact of Staphylococcus aureus bacteremia in COVID-19 patients6
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study6
Group A Streptococcus invasive infection in children: Epidemiologic changes and implications5
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures5
Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa5
Diagnostic accuracy of combining C-Reactive protein and Alvarado Score among 2-to-20-year-old patients with acute appendicitis suspected presenting to Emergency Departments5
Sepsis Code: dodging mortality in a tertiary hospital5
Current microbiological aspects of community respiratory infection beyond COVID-195
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome5
Ceftazidime-avibactam5
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives5
Optimized identification of microorganisms directly from positive blood cultures by MALDI-TOF to improve antimicrobial treatment5
Impact of the implementation of a Sepsis Code Program in medical patient management: a cohort study in an Internal Medicine ward5
Ceftobiprole: a clinical view5
Antibacterial spectrum of cefiderocol5
Unusual isolation of Pseudoglutamicibacter cumminsii in urine culture5
Tedizolid: new data and experiences for clinical practice5
Streptococcus cristatus, an infrequent cause of bacteremia and infective endocarditis. Case report and literature review4
Mechanism of action of cefiderocol4
In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals4
Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza4
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper4
Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-194
Suppressive antibiotic treatment with dalbavancin. A case report4
Immune treatment in COVID-194
Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications4
Increased severity in SARS-CoV-2 infection of minorities in Spain4
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper4
Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care4
Diagnostic accuracy of procalcitonin for bacteremia in the emergency department: a systematic review4
Respiratory consequences after COVID-19: outcome and treatment4
Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients4
Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outb4
Clinical implications of the genus Mycoplasma4
Bioinformatics approaches to the study of antimicrobial resistance4
Identificación de creencias y actitudes relacionadas con la desprescripción en pacientes VIH+ de edad avanzada: Proyecto ICARD4
A systematic review and expert’s analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain4
Increased infections by herpes simplex virus type 1 and polymicrobials of the genital tract, in the general population of a Spanish middle city4
Community-acquired pneumonia: similarities and differences between European and American guidelines – A narrative review –4
Methicillin-resistant Staphylococcus epidermidis infectious keratitis: Clinical and microbiological profile4
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program4
SARS-CoV-2 infection presenting as acute acalculous cholecystitis4
Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses4
Overview of virus and cancer relationships. Position paper4
Effectiveness, safety, and economic impact of the bictegravir/emtricitabine/tenofovir alafenamide regimen in real clinical practice cohort of HIV-1 infected adult patients4
Brain abscesses caused by anaerobic microorganisms: a systematic review4
Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain4
Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospit4
Current treatment of nosocomial pneumonia and ventilator-associated pneumonia4
Identifying the most important data for research in the field of infectious diseases: thinking on the basis of artificial intelligence4
Value of syndromic panels in the management of severe community-acquired pneumonia3
Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort3
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections3
Respiratory syncytial virus: A new era3
COVID in Pediatric Age: an opinion paper3
Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission3
Expert opinion on strategies to improve vaccination coverage against seasonal influenza3
Past and future of HIV infection. A document based on expert opinion3
New evidence in severe pneumonia: meropenem-vaborbactam3
Choice of influenza vaccine in people over 65 years old. Analysis of reports from international vaccination advisory committees3
Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment3
Impact of one year of pandemic on Spanish Intensive Care Units3
Pseudocitrobacter anthropi sepsis in a patient with complicated urinary tract infection3
High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife3
Bacteremia caused by Eikenella corrodens in a patient with pelvic inflammatory disease3
Report of sexually transmitted infections prevalence in asymptomatic pregnant women under 25 years old in Lleida, Spain3
Real-world efficacy of switching to bictegravir/ emtricitabine/tenofovir alafenamide in pretreated patients with triple therapy containing rilpivirine3
High-dose trivalent influenza vaccine: safety and immunogenicity3
Variability between health areas in antibiotic consumption among pediatric outpatients of Principado de Asturias, Spain (2005-2018)3
COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications3
Usefulness of thoracic ultrasound for diagnosis and follow-up of pneumonia3
Efficacy of early use of remdesivir: a systematic review of subgroup analysis3
Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient3
Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?3
Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa3
Persistence and viability of SARS-CoV-2 in primary infection and reinfections3
Actions and attitudes on the immunized patients against SARS-CoV-23
The role of cefiderocol in clinical practice3
Air pollution and health prevention: A document of reflection3
Introduction to XI Updating Course of Antimicrobials and Infectious Diseases3
Comparative study of the COVID-19 admissions between first and second wave in a cohort of 1,235 patients2
Ceftolozane-tazobactam in nosocomial pneumonia2
Ceftobiprole medocaril2
Comparison of quality of life in patients living with HIV infection through pharmaceutical care according to CMO methodology vs. conventional follow-up. MAS-VIH project2
Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections2
Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis2
Real-life experience of hepatitis C treatment in a Spanish prison2
Treatment of infections caused by carbapenemase-producing Enterobacterales2
New trends in antifungal treatment: What is coming up?2
Usefulness of MALDI-TOF and REP-PCR against PFGE for the epidemiological study of Acinetobacter baumannii2
Successful management of remdesivir extravasation2
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project2
Utility of the blood culture in infection of the urinary tract with fever in the elderly2
Use of clinical vignettes to screen general practitioners who can participate in a clinical trial about stopping antibiotic treatment when this is no longer necessary2
Decalogue for the selection of oral antibiotics for lower respiratory tract infections2
Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-20172
Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer2
New predictive models of bacteremia in the emergency department: a step forward2
Current situation of sepsis care in Spanish emergency departments2
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal2
Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital2
Evaluation of a lateral flow immunoassay to detect CTX-M extended-spectrum β-lactamases (ESBL) directly from positive blood cultures for its potential use in Antimicrobial Stewardship programs2
Exploring therapeutic options for mild diabetic-related foot infections: a comparative in vitro study of cefditoren versus amoxicillin/clavulanic acid2
Ceftaroline2
Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina2
Secondary Bordetella hinzii pneumonia in a patient with SARS-CoV-2 infection2
The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued2
Time to decision in sepsis2
Ceftaroline in severe community-acquired pneumonia2
Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?2
Current approach to skin and soft tissue infections. Thinking about continuity of care2
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting2
A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes2
First case of Arcobacter cryaerophilus in paediatric age in Spain2
Retrospective diagnosis of lymphatic tuberculosis in frozen samples using two genetic amplification methods, Xpert® MTB/RIF ULTRA and Abbott RealTime MTB Assay2
Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex™ NG&DR Assay (Seegene®) in a tertiary hospital from Madrid, Spain2
Mycoplasma genitalium in Primary Care: Prevalence and azithromycin resistance in Santiago de Compostela Health Care Area2
Identification of curved Gram-negative rods by MALDI-TOF mass spectrometer in a patient with Fournier ́s gangrene. A bacteremia caused by Desulfovibrio desulfuricans and Escherichia coli2
Antimicrobial stewardship program in an Intensive Care Unit: A retrospective observational analysis of the results 15 months after its implementation2
Shigellosis attended in the emergency department of a regional hospital in southeastern Spain: from their presence to multiresistance2
Two cases of Prevotella oris causing serious pleuropulmonary infections2
Urgent need for a rapid microbiological diagnosis in critically ill pneumonia2
Nosocomial meningitis caused by ESBL- and OXA-48-producing Klebsiella pneumoniae and treated with ceftazidime-avibactam. Report of one case and review of the literature2
Unresolved issues in the epidemiology and diagnosis of bacteremia: an opinion paper2
Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)2
Treatment guidelines for multidrug-resistant Gram-negative microorganisms2
Impact of Sepsis Flow Chip, a novelty fast microbiology method, in the treatment of bacteremia caused by Gram-negative bacilli2
Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis2
Eumycetomas by Fusarium oxysporum and Madurella mycetomatis. Description of two cases and literature review2
Global strategy in the treatment of HIV infection in 20222
New evidence in severe pneumonia: imipenem/ cilastatin/relebactam2
Microbial etiology of bacterial chronic prostatitis: systematic review2
Evolution of adherence to hand hygiene in health care professionals in a third level hospital in relation to the SARS-CoV-2 pandemic2
What happened to microbiological diagnosis in 2020 beyond COVID-19?2
Microscopy vs. molecular biology in the diagnosis of intestinal protozoal infections, is it time for a change?2
Management of hyperinflammation in COVID-19 patients2
Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort2
RedLabRA; a Spanish Network of Microbiology Laboratories for the Surveillance of Antibiotic Resistant Microorganisms2
Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases2
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-20202
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León2
Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis2
Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-22
Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus2
Pulmonary nocardiosis after covid-19 infection: case report and literature review2
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-21
Change in Klebsiella pneumoniae susceptibility profile after the arrival of ceftazidime-avibactam in an Argentinean intensive care unit: a new ecological landscape1
Pulmonary Nocardiosis. A case report1
Corneal abscess caused by Filobasidium uniguttulatum. Case report and literature review on cryptococcal keratitis1
Evolution of serotypes and antibiotic susceptibility of Salmonella spp in the Castellón Health District (Spain)1
Eikenella corrodens brain abscess after frontal sinusitis in immunocompetent patient1
Optic neuritis as sign presentation of acute disseminated encephalomyelitis following Mycoplasma pneumoniae infection1
Recommendations for the prevention of healthcare-associated infections in nursing homes1
Rare infectious complication after intramuscular self-injections1
Septic arthritis caused by Bacteroides thetaiotaomicrom: A case report and review1
Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT)1
Influenza and cardiorespiratory events: a clinical-epidemiological review with a multidisciplinary point of view1
Bacteriemia by disseminated pulmonary nocardiosis1
Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency1
Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital1
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain1
Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications1
Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications1
Treatment of Clostridioides difficile infection: from guidelines to clinical practice1
Primary meningococcal arthritis1
COVID-19 in donation and transplant1
Aislamientos de Turicella otitidis en exudados óticos durante el año 20201
Bacteremia caused by Clostridium sporogenes in an oncological patient1
Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over1
Cavitary pneumonia and empyema thoracis caused by multidrug resistant Nocardia otitidiscaviarum in an elderly patient1
Herpes zoster complicated with aseptic meningitis after cardiac transplantation: Report of two cases and review of the literature1
Therapeutic strategy in the transplanted patient1
EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus1
A case report of multiple abscess co-infected with Eggerthella lenta and Desulfovibrio desulfuricans identificated with MALDI-TOF mass spectrometer1
Prognostic value of static and dynamic biomarkers in COVID-19 patients: a prospective cohort study1
Serratia marcescens as cause of delayed onset endophtalmitis1
Monocyte distribution width (MDW) as an infection indicator in severe patients attending in the Emergency Department: a pilot study1
Amoebic liver abscess in a patient from Gambia1
Vaccination strategies against SARS-CoV-2: General impact on the development of the pandemic1
Lessons from COVID-19 for future disasters: an opinion paper1
Models for bacteraemia risk prediction. Clinical implications1
Cefiderocol. Summary and conclusions1
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients1
Incidence of intravenous colistin nephrotoxicity in hospitalized patients1
COVID-19: Some unresolved issues1
Prevalence of microbiologically-confirmed influenza in patients with influenza-like illness in primary care and clinical and epidemiological characteristics1
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician1
A case report. Rediscovering tuberculostatics drugs: skin rash and pyrazinamide1
Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy1
A rare case of cardiac alveolar echinococcosis without any complications for eight years1
Ability of qSOFA1-lactate to predict 30-day mortality in patients seen for infection in the Emergency Department1
Neisseria meningitidis bacteraemia and SARS-CoV-2 infection: a coinfection that reminds previous epidemic outbreaks1
Isolation of Turicella otitidis in ear infection1
Candida bracarensis, an emerging yeast involved in human infections1
Impact of vaccination on the epidemiology and prognosis of pneumonia1
Septic shock and empyema induced by Pasteurella multocida1
Fatal sepsis months after bladder instillations with Mycobacterium bovis in patient with SARS-CoV-2 infection1
Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department1
Fournier's gangrene secondary to inguinoperineal abscess caused by Acidaminococcus intestini and Streptococcus gallolyticus spp. pasteurianus1
Endocarditis due to Kytococcus schroeteri: two cases report1
Putative Secondary Structure at 5’UTR as a Potential Antiviral Target against SARS-CoV-21
Clinically important pharmacokinetic drug-drug interactions with antibacterial agents1
Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine1
Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city1
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia1
0.048987150192261